series-a
Stage
1
Investors
About
Targovax AS is a clinical-stage biotech company developing immuno-oncology therapies based on targeted cancer vaccines aimed at activating the patient's immune system to destroy tumors.
Explore Targovax AS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.